This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (32)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Richard J. Kelly, MD; Robert J. Cowan, MD; Carolyn B. Ferree, MD; Milton Raben, MD; C. Douglas Maynard, MD

JAMA. 1979;242(26):2855-2857.

Abstract
Ninety-two patients with histologically proved carcinoma of the lung were studied retrospectively to determine the usefulness of liver, brain, and bone imaging in their examination and treatment. Occult metastatic liver disease was observed in two (5.3%) of 38 asymptomatic patients, while four (6.6%) of 58 neurologically intact patients had abnormal brain scans. Eight (13.6%) of 59 asymptomatic patients had metastatic bone disease. Seven (18.4%) of 38 patients with no clinical evidence of metastatic disease to liver, brain, or bone had at least one type of abnormal radionuclide study. More than half (52.5%) of the patients studied had at least one abnormal scan exclusive of symptoms. Radionuclide imaging is a useful procedure in the initial evaluation and subsequent management of lung cancer.

(JAMA 242:2855-2857, 1979)

Author Affiliations
From the Department of Radiology, Divisions of Nuclear Medicine (Drs Kelly, Cowan, and Maynard) and Radiation Therapy (Drs Ferree and Raben), Bowman Gray School of Medicine, Winston-Salem, NC.

Footnotes
Reprint requests to Department of Radiology/Nuclear Medicine, Bowman Gray School of Medicine, 300 S Hawthorne Rd, Winston-Salem, NC 27103 (Dr Kelly).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Role of Whole-Body Bone Scanning and Clinical Factors in Detecting Bone Metastases in Patients With Non-small Cell Lung Cancer
Erturan et al.
Chest 2005;127:449-454.
ABSTRACT | FULL TEXT  

Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer
Ann. Thorac. Surg. 2001;71:425-433.
ABSTRACT | FULL TEXT  

Extrathoracic staging is not necessary for non-small-cell lung cancer with clinical stage T1-2 N0
Tanaka et al.
Ann. Thorac. Surg. 1999;68:1039-1042.
ABSTRACT | FULL TEXT  

Surgeons’ assessment of symptoms suggesting extrathoracic metastases in patients with lung cancer
Guyatt et al.
Ann. Thorac. Surg. 1999;68:309-315.
ABSTRACT | FULL TEXT  

Suspected Non–Small Cell Lung Cancer: Incidence of Occult Brain and Skeletal Metastases and Effectiveness of Imaging for Detection—Pilot Study
IV et al.
Radiology 1999;211:137-145.
ABSTRACT | FULL TEXT